Moderna’s COVID-19 Vaccine Nearly 95% Effective
Published by the Environmental News Service
CAMBRIDGE, Massachusetts, November 16, 2020 (ENS) – Moderna, a Massachusetts biotechnology company pioneering therapeutics and vaccines, today announced that its COVID-19 vaccine candidate, mRNA-1273, has been rated 94.5 percent effective by the U.S. government. Moderna intends to request an Emergency Use Authorization from the U.S. Food and Drug Administration.
Read the full article at: http://ens-newswire.com/2020/11/16/modernas-covid-19-vaccine-nearly-95-percent-effective/
